We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK's MHRA Amends Clinical Trial Regulations
UK's MHRA Amends Clinical Trial Regulations
August 8, 2006
The Medicines and Healthcare products Regulatory Agency (MHRA), the UK equivalent of the FDA, has amended the country’s clinical trial regulations to bring them into compliance with the European Commission’s Good Clinical Practice (GCP) Directive (Directive 2005/28/EC1).
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor